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Abstract
Background: Osteoarthritis (OA) is characterized by degeneration of articular cartilage. Animal models of OA induced 
are a widely used tool in the study of the pathogenesis of disease. Several proteomic techniques for selective 
extraction of proteins have provided protein profiles of chondrocytes and secretory patterns in normal and 
osteoarthritic cartilage, including the discovery of new and promising biomarkers. In this proteomic analysis to study 
several proteins from rat normal articular cartilage, two-dimensional electrophoresis and mass spectrometry (MS) were 
used. Interestingly, latexin (LXN) was found. Using an immunohistochemical technique, it was possible to determine its 
localization within the chondrocytes from normal and osteoarthritic articular cartilage.
Results: In this study, 147 proteins were visualized, and 47 proteins were identified by MS. A significant proportion of 
proteins are involved in metabolic processes and energy (32%), as well as participating in different biological functions 
including structural organization (19%), signal transduction and molecular signaling (11%), redox homeostasis (9%), 
transcription and protein synthesis (6%), and transport (6%). The identified proteins were assigned to one or more 
subcellular compartments.
Among the identified proteins, we found some proteins already recognized in other studies such as OA-associated 
proteins. Interestingly, we identified LXN, an inhibitor of mammalian carboxypeptidases, which had not been 
described in articular cartilage. Immunolabeling assays for LXN showed a granular distribution pattern in the 
cytoplasm of most chondrocytes of the middle, deep and calcified zones of normal articular cartilage as well as in 
subchondral bone. In osteoarthritic cartilage, LXN was observed in superficial and deep zones.
Conclusions: This study provides the first proteomic analysis of normal articular cartilage of rat. We identified LXN, 
whose location was demonstrated by immunolabeling in the chondrocytes from the middle, deep and calcified zones 
of normal articular cartilage, and superficial and deep zones of osteoarthritic cartilage.
Background
Articular cartilage is a specialized connective tissue and
its principal functions are reduction of friction in the
joint, resistance to compressive forces and distribution of
load [1]. Macromolecules that constitute the extracellular
matrix (ECM) of cartilage such as collagens and proteo-
glycans (PGs) make the reproducibility of protein profiles
difficult, interfering with isoelectric focusing (IEF) and
masking minor cell proteins [2]. Previous studies
reported the use of different selective extraction tech-
niques in human and animal cartilage models, which
allowed the rapid and efficient detection of protein
expression patterns [3-5].
Proteomic technology is a useful tool in the search for
markers aimed at understanding the molecular mecha-
nisms in health and disease conditions. Recently, the pro-
tein profile of human articular chondrocytes isolated
from cartilage of normal and osteoarthritic individuals
was described [6,7]. In other studies where secreted pro-
tein patterns in osteoarthritic cartilage explants were
compared against normal tissue, increases of collagen
type II and activin A were reported [2]. Here we per-
formed the first proteomic analysis of rat normal articu-
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Page 2 of 8lar cartilage and, interestingly, latexin (LXN), a protein
not previously detected in cartilage, was identified by
MALDI TOF/TOF mass spectrometry (MS) from a spot
resolved by two-dimensional gel electrophoresis (2-DE).
LXN is a 25-kDa protein that functions as a carboxypep-
tidase inhibitor in mammals and was originally described
in the rat lateral neocortex [8]. It has recently been
reported that LXN is expressed in proliferating and pre-
hypertrophic chondrocytes during skeletogenesis and
bone fracture repair [9]. However, this protein has not
been described in mammalian articular cartilage and its
role in regulation of chondrocyte function is unknown.
Results and discussion
Extraction method and 2-D reference map
Cartilage samples are difficult to fractionate and best
results have been observed using a method based on PGs
and collagen species removal from protein extracts [2,3].
After test-reported protocols, an improved method
resulted in combining purification methods in order to
obtain a reliable separation of proteins by 2-DE. First,
PGs were eliminated by selective precipitation using
cetylpyridinium chloride (CPC). Next, they were precipi-
tated using methanol and, finally, a commercial cleaning-
precipitation method was used. With this procedure it
was possible to resolve 147 silver-stained spots on each
analytical gel loaded with 100 μg of total protein extract.
Reproducibility of protein spot profiles was confirmed on
triplicate gels from three independent cartilage extracts.
A total of 47 proteins from 66 selected and excised
spots according to intensity (71.2%) were identified using
MS/MS. Proteins identified are listed in Additional file 1,
Table S1, indicated on the 2-D reference map (Figure 1),
and predicted cell location based on QuickGO for Gene
Ontology (GO) database at the EBI is presented http://
www.ebi.ac.uk/QuickGO/ (Figure 2A).
The identified proteins were assigned to one or more
subcellular compartment such as cytoplasm, soluble
cytosol fractions, cytoskeleton, endoplasmic reticulum
(ER)/Golgi complex, plasma membrane, mitochondria,
lysosome, nucleus and a proportion of secreted proteins.
Biological function
Proteins categorized according to known biological pro-
cesses are shown in Figure 2B. For 98% of the proteins, at
least one function within the GO database was found. It
was observed that a significant proportion of identified
proteins are involved in cellular metabolic processes
(32%) including enzymes such as esterases, sulfatases,
hydrolases, kinases, dehydrogenases, ligases, and lyases.
Lactoylglutathione lyase, a catalyst for the conversion of
methylglyoxal to D-lactic acid via intermediate SD-lac-
toylglutation [10], may be involved in the survival of
chondrocytes in an anaerobic environment.
A small percentage of identified proteins are involved
in other functions including structural organization
(19%), signal transduction and molecular signaling (11%),
redox homeostasis (9%), transcription and protein syn-
thesis (6%), and transport (6%).
Among the identified proteins, some were already rec-
ognized in other studies as OA-associated proteins: eno-
lase, peroxiredoxin, and annexin in human cartilage
[11,12].
In addition, a new finding in articular cartilage was the
presence of CLIC6 protein, a member of the selective ion
channel family [13]. It was previously reported that mem-
brane conductance of rabbit articular chondrocytes was
determined by voltage-dependent Cl- channels [14].
Expression of voltage-dependent potassium channels was
observed from rat articular chondrocytes, suggesting a
role in regulating membrane potential [15]. Furthermore,
other studies reported the involvement of ion channels in
the processes of proliferation and differentiation of chon-
drocytes [16,17]. Future studies should demonstrate the
role of CLIC6 in the functions of chondrocytes.
Interestingly, in our analysis we found the presence of
LXN, a protein not previously reported in articular carti-
lage. This molecule is a carboxypeptidase inhibitor
(CPA1, 2) in rodents, mast cell (CPA3) and CPA4 in
humans [18]. LXN has been reported in different tissues
such as pancreas, lung, heart, prostate, kidney, ovary and
colon [19,20]. In the hematopoietic system, LXN has
been reported to influence aging of a negative regulator
of stem cell number [21]. Also, it has been suggested that
LXN is involved in pain perception according to the loca-
tion on nociceptive neurons in sensory ganglia [22], in
inflammation for its expression on stimulated mouse
macrophages [23] and LXN gene expression was identi-
fied in acute pancreatitis and inflammatory lung diseases
[24]. Moreover, LXN gene was upregulated in BMP-2-
treated C2C12 cells, suggesting a role in osteoblast differ-
entiation [25].
Immunohistochemical detection of LXN
Because it is the first time that LXN, a protein involved in
skeletogenesis and growth plaque chondrocyte and
osteoblast differentiation [9,26], has been observed in
articular cartilage, it was interesting to investigate the
localization of this molecule in normal and osteoarthritic
articular cartilage of rat. In normal articular cartilage,
LXN immunoreactivity was localized predominantly in
chondrocytes of middle and deep zones and was also
observed in cells of the calcified zone and subchondral
bone. Labels were distributed on a granular pattern in the
cytoplasm of most chondrocytes (Figure 3). In osteoar-
thritic cartilage the immunolabeling distribution was
confined to chondrocytes of superficial and deep zones in
a similar pattern to that of normal cartilage. Further stud-
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significant differences in expression levels of LXN in nor-
mal and osteoarthritic cartilage.
Positive and negative controls were performed on rat
kidney tissue. The LNX immunoreactivity from positive
control was observed in the cytoplasm of the most tubu-
lar epithelial cells. Negative control consisted of omission
of primary antibody (anti-LXN) and no staining was
observed (Figure 3).
Recently, LXN expression in the nucleus and cytoplasm
of proliferating and prehypertrophic chondrocytes in the
embryonic tibiae and callus during skeletogenesis and
skeletal regeneration was described [9]. It was also
reported that bone morphogenetic protein-2 (BMP-2)
signaling pathway regulates LXN expression during
chondrocyte/osteoblast differentiation [9]. To date, LXN
expression and localization in mature bone has not yet
been determined.
LXN has been reported as a negative regulator of a
number of stem cells through decreasing cell replication
and increasing apoptosis [21]. Chondrocytes within the
cartilage from elderly individuals remain in a quiescent
phase of the cell cycle and reduce the potential for
growth. This has been associated with changes in telom-
Figure 1 2-DE map of normal articular cartilage of rat (10% SDS-PAGE, pH 4-7, silver staining). Spots are shown according to pI and Mw. Iden-
tification of proteins from spots subjected to tryptic digestion followed by MS analysis are shown according to protein names [UniProt Knowledge-
base (UniProtKB)/Swiss-Prot] for Rattus norvegicus species.
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whether there is any involvement of LXN in mechanisms
of chondrocyte senescence.
On the other hand, it has been suggested that calcifica-
tion of articular cartilage is not necessarily associated
with degenerative conditions in OA, but rather may be a
secondary effect of aging [28,29]. Other authors have
reported that mineralization of articular cartilage is a
fundamental process in OA progression [30,31]. Accord-
ing to our results regarding LXN immunoreactivity in
chondrocytes of the deep and calcified zones and sub-
chondral bone, it raises the following question: Could
LXN be involved in the process of mineralization of artic-
ular cartilage during OA pathogenesis?
Conclusion
The present study provides the first protein analysis
based on 2-DE and MS of normal articular cartilage of
adult rat. In addition, this study demonstrated the expres-
sion and revealed the immunolocalization of LXN, a pro-
tein found in chondrocytes of middle, deep and calcified
zones of normal articular cartilage, and superficial and
deep zones of osteoarthritic cartilage.
Materials and methods
Tissue sampling
Animal samples were obtained following the Guidelines
of the Internal Committee for the Care and Use of Labo-
ratory Animals (NOM-069-ZOO-1999). Normal articular
and osteoarthritic cartilage was obtained from femoral
condyles and tibial plates of male adult Wistar rats (120-
150 g) and rats with OA induced by partial menisectomy
(20 days after surgery), respectively. This surgical proce-
dure for inducing osteoarthritic cartilage changes has
been described elsewhere [32].
Protein preparation was based on selective extraction
method with minor modifications [3]. Briefly, samples
were rinsed with PBS buffer, frozen in liquid nitrogen,
mechanically pulverized and suspended (100 mg carti-
lage/mL) in extraction buffer (500 mM NaCl, 50 mM
HEPES pH 7.2, complete™ protease inhibitor cocktail,
Roche, Germany). Samples were stirred overnight at 4°C.
Insoluble material was removed by centrifugation (6000 ×
g, 5 min), and the supernatant was selectively precipi-
tated adding CPC, 1% (w/v). This quaternary ammonium
compound forms a water- and alcohol-insoluble complex
with glycosaminoglycans [33]. This procedure allowed
the removal of anionic macromolecules that interfere
with IEF [2,3]. After centrifugation (6000 × g, 5 min) the
PG and CPC aggregates were eliminated. Then, superna-
tant was precipitated with methanol (400 μL methanol/
100 μL sample), centrifuged at 14,000 × g for 30 min and
suspended again in 4 volumes of methanol. The pellet
obtained was resuspended in sample buffer [7 M urea, 2
M thiourea, 4% (w/v) CHAPS, 2% (w/v) immobiline pH
gradient (IPG) buffer and 40 mM dithiothreitol (DTT)].
Additionally, we used a method for selective protein pre-
cipitation and cleaning (2D Clean-Up Kit, Amersham
Biosciences, USA). The precipitate was diluted in rehy-
dration stock solution (7 M urea, 2 M thiourea, 2% (w/v)
CHAPS, 0.5% (w/v) IPG buffer and traces of bromophe-
nol blue) supplemented with DTT at 7 mg/2.5 mL of
rehydration stock solution. Protein concentrations were
measured using 2D Quant Kit (Amersham Biosciences,
USA) according to the manufacturer's recommendations.
2-DE
Protein extract resuspended in rehydration solution (250
μL) was used to rehydrate Immobiline Drystrip Gels, pH
4-7, 13 cm (GE Healthcare, Sweden) for 18 h at room
temperature. Electrofocusing was performed in an Ettan
IPGphor 3 Isoelectric Focusing System (GE Healthcare,
USA) with an IPG at 16-20 kVh for 5 h. Then, IPG strips
were incubated in reducing and alkylating 2-DE equili-
Figure 2 Gene ontology annotation of the proteins identified in 
articular cartilage of rat by MS/MS. Results were obtained from 
QuickGO for Gene Ontology (GO) database at the EBI at http://
www.ebi.ac.uk/QuickGO/. (A) Distribution of identified proteins ac-
cording to subcellular location. (B) Functional distribution of identified 
proteins implicated in biological processes.
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Figure 3 Immunolabeling of LXN protein in normal articular and osteoarthritic cartilage of rat. Cryosections were stained with anti-LXN (green) 
and nuclei were counterstained with propidium iodide (red). (A) Positive control. (B) Negative control. (C, E, G) Normal articular cartilage (total thick-
ness, superficial and middle zones, deep zone, respectively). (D, F, H) Osteoarthritic cartilage (total thickness, superficial and middle zones, deep zone, 
respectively).
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29.3% (w/v) glycerol, 2% (w/v) sodium dodecyl sulfate
(SDS), traces of bromophenol blue and DTT (100 mg/10
mL EB) or iodoacetamide (250 mg/10 mL EB) for 10 min
each, respectively. For SDS-polyacrylamide gel electro-
phoresis (PAGE), a standard vertical electrophoresis sys-
tem was used with 10% polyacrylamyde gels (15 cm × 13
cm) using Gibco BRL V16 gel system (Life Technologies,
Gaithersburg, MD) according to Laemmli [34]. Gels were
stained with Colloidal Coomassie Blue G-250 (Bio-Safe
Coomassie Stain, Bio-Rad Laboratories, USA) or silver.
Image acquisition and data analysis
A digital image of the gels was obtained using scanning
densitometry (Image Scanner, Amersham Biosciences
Corporation, USA) and analyzed with Image Master 2D
Platinum software, version 7.0 (GE Healthcare Life Sci-
ences, Switzerland).
Spot excision, destaining and drying
For identification of individual 2-D resolved spots, they
were excised from gels and transferred to individual
Eppendorf tubes. Coomassie Blue dye was removed with
500 μL of 50 mM ammonium bicarbonate (AMBIC) solu-
tion in 50% (w/v) acetonitrile (ACN), incubated at 50°C
for 5 min and then removed. This procedure was
repeated twice. Dehydration was carried out by adding
100 μL of ACN for 5 min at room temperature. The
supernatant was then removed and gel fragments were
allowed to dry.
Trypsin digestion and peptide extraction
Peptide digestion was conducted with an in-house-modi-
fied protocol [35]. Polyacrylamide pieces containing the
spots were rehydrated with sequencing-grade trypsin
solution (25 ng/μL, Promega, USA) for 10 min and the
excess was removed. Then, 50 mM AMBIC was added to
cover the gel completely and incubated overnight at 37°C.
Further, 20 μL AMBIC was added to the sample, incu-
bated for 10 min, centrifuged at 14,000 × g for 1 min, and
the supernatant was removed and transferred to an
empty 0.5 mL plastic vial. Peptide extraction solution
[50% (w/v) ACN/0.5% (w/v) trifluoroacetic acid (TFA)]
was added, incubated for 10 min at room temperature,
vortex mixed and centrifuged at 14,000 × g for 30 sec.
The supernatant was carefully collected with a pipette
and combined with previous fractions in the 0.5-mL plas-
tic vial. This last step was repeated twice. Protein digests
were concentrated/desalted using a solid-phase extrac-
tion modified protocol with C18-ZipTips (Millipore Cor-
poration, Bedford, MA, USA). Peptides were eluted in 15
μL of 50% (w/v) ACN/0.1% (w/v) TFA solution.
MS
Peptides were analyzed using a 4800 Plus MALDI TOF/
TOF mass spectrometer (Applied Biosystems, Framing-
ham, MA, USA) at the INMEGEN facility. MS/MS spec-
tra were analyzed using Paragon Algorithm (Protein Pilot
Software, Applied Biosystems) against the UniProt
Knowledgebase (UniProtKB)/Swiss-Prot for Rattus nor-
vegicus species plus contaminant protein databases.
Search parameters were adjusted for cystein alkylation
with iodoacetamide. Confidence interval ≥ 99% was used
for protein identification (Unused ProtScore > 2.0) (Addi-
tional file 2, Table S2).
Immunohistochemistry
Full-thickness rat normal and osteoarthritic articular car-
tilage from weight-bearing areas was fixed with 4% PBS-
paraformaldehyde at 4°C, cryosectioned (SM2000 R Slid-
ing Microtome, Leica, Heidelberg, Germany), and
mounted on gelatin-coated slides. Sections were incu-
bated overnight at 4°C with an anti-LXN goat polyclonal
antibody (1:50, sc-47089, Santa Cruz Biotechnology,
Santa Cruz, CA, USA) followed by fluorescein isothiocy-
anate (FITC)-tagged rabbit anti-goat IgG (1:60; Zymed
Laboratories, South San Francisco, CA) for 1 h at room
temperature. Nuclei were counterstained with propidium
iodide for 5 min (1:1000; Vector Laboratories, Burl-
ingame, CA). Similar preparations where primary anti-
body was omitted were used for negative controls.
Positive controls were conducted on rat kidney tissue.
Confocal microscopy
Double-immunolabeled sections were viewed through a
confocal laser scanning microscope (TCP-SP2, Leica,
Heidelberg, Germany) using a 100 × oil-immersion plan
Apochromat objective (numerical aperture 1.4). Ten to
fifteen consecutive single sections were obtained at 0.8-
to 1.0-μm intervals and sequentially scanned for two
channels throughout the z-axis of the sample. The result-
ing stack of images was projected and analyzed on the 2-
D plane using a pseudocolor display green (FITC) and red
(propidium iodide). Fluorochromes in double-labeled
samples were excited at 488 nm (for FITC) and 554 nm
(for propidium iodide) wavelengths.
Additional material
Additional file 1 Functional classification of proteins from normal 
articular cartilage of rat identified by MS/MS.
Additional file 2 Detail identified proteins by MS/MS. This informa-
tion includes protein reported with confidence > 99% (Unused 
ProtScore > 2.0), with have at least two identified peptides and stan-
dard proteins.
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